[Federal Register Volume 63, Number 76 (Tuesday, April 21, 1998)]
[Notices]
[Pages 19735-19736]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-10406]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Science Advisory Board to the National Center for Toxicological 
Research; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Science Advisory Board to the National Center 
for Toxicological Research (NCTR).
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA regulatory issues.
    Date and Time: The meeting will be held on May 6, 1998, 9 a.m. to 5 
p.m., and May 7, 1998, 9 a.m. to 11 a.m.
    Location: NCTR, Jefferson, AR.
    Contact Person: Ronald F. Coene, NCTR (HFT-10), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-6696, 
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12559. Please call the 
Information Line for up-to-date information on this meeting.
    Agenda: The board will be presented with draft reports on 
evaluations of three of NCTR's programs in Information Technology, 
Biometry and Risk Assessment, and Neurotoxicology for their review, 
discussion, and approval. The draft reports are the products of three 
site visit teams who conducted onsite reviews over the last 9 months. 
The staff from these programs will provide a preliminary response to 
the issues raised and recommendations made. A progress report will be 
presented to the board on the recommendations it made at its last 
meeting on NCTR's Estrogen Knowledge Base project. Also, there will be 
a Center Director's update.
    Procedure: On May 6, 1998, from 9 a.m. to 5 p.m., and May 7, 1998, 
from 9 a.m. to 11 a.m., the meeting is open to the public. Interested 
persons may present data, information, or views, orally or in writing, 
on issues pending before the committee. Written submissions may be made 
to the contact person by April 17, 1998. Oral presentations from the 
public will be scheduled between approximately 11 a.m. and 12 m., on 
May 7, 1998. Time allotted for each presentation may be limited. Those 
desiring to make formal oral presentations should notify the contact 
person before April 17, 1998, and submit a brief statement of the 
general nature of the evidence or arguments they wish to present, the 
names and addresses of proposed participants, and an indication of the 
approximate time requested to make their presentation.
    Closed Committee Deliberations. On May 7, 1998, from 1 p.m. to 2:30 
p.m., the meeting will be closed to permit discussion where disclosure 
would constitute a clearly unwarranted invasion of personal privacy (5 
U.S.C. 552b(c)(6)). This portion of the meeting will be closed to 
permit discussion of information concerning individuals associated with 
the research programs at NCTR.
    The Commissioner approves the scheduling of meetings at locations 
outside of the Washington, DC, area on the basis of the criteria of 21 
CFR 14.22 of FDA's regulations relating to public advisory committees.

[[Page 19736]]

    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: April 14, 1998.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 98-10406 Filed 4-20-98; 8:45 am]
BILLING CODE 4160-01-F